FindMyKOL
Clinical trialNCT07840365RecruitingPhase 3Interventional

Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion

SponsorTexas Cardiac Arrhythmia Research FoundationEnrollment234Atrial Fibrillation (AF)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This randomized study was designed to compare two antithrombotic regimens (long-term half-dose apixaban vs long-term aspirin after 45-days of full-dose apixaban) after successful Watchman implantation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Texas Cardiac Arrhythmia Institute, St. David'S Medical Center

    Austin, Texas, United States

    Andrea Natale
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Half-Dose of novel OACLow-dose ASA
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Sept 2026
Primary completion
15 Dec 2028
Completion
30 Sept 2029
Last update posted
5 Oct 2026
Registered enrollment
234
Registry id
NCT07840365

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.